Ye CG - Search Results

1

Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.

Ye CG, Chen GG, Ho RLK, Merchant JL, He ML, Lai PBS. Ye CG, et al. Biochim Biophys Acta. 2013 Dec;1833(12):2970-2979. doi: 10.1016/j.bbamcr.2013.08.001. Epub 2013 Aug 13. Biochim Biophys Acta. 2013. PMID: 23954442 Free PMC article.

2

ZBP-89 reduces histone deacetylase 3 by degrading IkappaB in the presence of Pin1.

Ye CG, Liu L, Chen GG, Tang XL, He Z, He ML, Lai PB. Ye CG, et al. J Transl Med. 2015 Jan 27;13:23. doi: 10.1186/s12967-015-0382-7. J Transl Med. 2015. PMID: 25623232 Free PMC article.

3

ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells.

To AK, Chen GG, Chan UP, Ye C, Yun JP, Ho RL, Tessier A, Merchant JL, Lai PB. To AK, et al. Biochim Biophys Acta. 2011 Jan;1813(1):222-30. doi: 10.1016/j.bbamcr.2010.09.005. Epub 2010 Sep 17. Biochim Biophys Acta. 2011. PMID: 20850481 Free PMC article.

4

Susceptibility of Hep3B cells in different phases of cell cycle to tBid.

Ma SH, Chen GG, Ye C, Leung BC, Ho RL, Lai PB. Ma SH, et al. Biochim Biophys Acta. 2011 Jan;1813(1):179-85. doi: 10.1016/j.bbamcr.2010.10.009. Epub 2010 Oct 20. Biochim Biophys Acta. 2011. PMID: 20969896 Free article.

5

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma.

Liu LP, Hu BG, Ye C, Ho RL, Chen GG, Lai PB. Liu LP, et al. Br J Cancer. 2014 Feb 18;110(4):1066-73. doi: 10.1038/bjc.2013.787. Epub 2013 Dec 17. Br J Cancer. 2014. PMID: 24346287 Free PMC article.

6

Therapeutic efficacy of improved α-fetoprotein promoter-mediated tBid delivered by folate-PEI600-cyclodextrin nanopolymer vector in hepatocellular carcinoma.

Hu BG, Liu LP, Chen GG, Ye CG, Leung KK, Ho RL, Lin MC, Lai PB. Hu BG, et al. Among authors: ye cg. Exp Cell Res. 2014 Jun 10;324(2):183-91. doi: 10.1016/j.yexcr.2014.04.005. Epub 2014 Apr 13. Exp Cell Res. 2014. PMID: 24726886

7

ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.

Kong X, Xu P, Cai WJ, Wang HG, Li BB, Huang GL, He ZW, Chen G, Ye CG. Kong X, et al. Among authors: ye cg. BMC Cancer. 2018 Apr 13;18(1):419. doi: 10.1186/s12885-018-4349-y. BMC Cancer. 2018. PMID: 29653560 Free PMC article.

8

Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.

Ye CG, Wu WK, Yeung JH, Li HT, Li ZJ, Wong CC, Ren SX, Zhang L, Fung KP, Cho CH. Ye CG, et al. Cancer Lett. 2011 May 28;304(2):90-6. doi: 10.1016/j.canlet.2011.01.025. Epub 2011 Mar 4. Cancer Lett. 2011. PMID: 21377266

9

A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.

Lu M, Kong X, Wang H, Huang G, Ye C, He Z. Lu M, et al. Oncotarget. 2017 Jan 31;8(5):8775-8784. doi: 10.18632/oncotarget.14452. Oncotarget. 2017. PMID: 28060739 Free PMC article.

10

Increased glutathione and mitogen-activated protein kinase phosphorylation are involved in the induction of doxorubicin resistance in hepatocellular carcinoma cells.

Ye CG, Yeung JH, Huang GL, Cui P, Wang J, Zou Y, Zhang XN, He ZW, Cho CH. Ye CG, et al. Hepatol Res. 2013 Mar;43(3):289-99. doi: 10.1111/j.1872-034X.2012.01067.x. Epub 2012 Aug 6. Hepatol Res. 2013. PMID: 22882382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters